Lily WANG | 王莉莉
Head of IP | 知识产权总负责人
Ascentage Pharma | 亚盛医药
Lily Wang is working in Ascentage Pharma as
Head of IP, Director, responsible for corporate IP management, global IP
portfolio life cycle management, and support multiple functions, such as
discovery, CMC, preclinical, clinical and BD to provide IP advices.
Lily worked in WuXi Biologics as IP Counsel,
Associate Director, before joining Ascentage Pharma, responsible for patent portfolio
management, patent filling & prosecution, patent search & analysis, and
patent transfer & license.
Lily has been working in Novartis Knowledge
Center for more than five years, mainly focus on the area of competitive
intelligence, patentability & FTO analysis. Before joining Novartis, she
worked as a project manager in Sinoipro IP management and technology transfer
company (Former affiliation of Office of Technology Transfer, Shanghai
Institutes of Biological Sciences, Chinese Academy of Sciences), and a patent
specialist for three years in Allist Pharmaceutical company, responsible for
patentability & FTO analysis, patent drafting, filling & prosecution.
Lily Wang graduated from Xiangya Medical
School, Central South University in 2005, and earned a M.S. in Medicinal
Chemistry from Shanghai Institute of Materia Medica, Chinese Academy of
Sciences in 2008. She received Certificate of Patent Attorney of China in 2012
and the Master of Law (JM) in Fundan University in 2013.